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ANG-(1-7); lipodystrophy; liver steatosis; atherosclerosis; renin angiotensin system THE METABOLIC SYNDROME REFERS to a clustering of metabolic abnormalities, including excess body fat, dyslipidemia, hypertension, and hyperglycemia (2) . Although excess fat is considered as highly deleterious, adipose tissue deficiency, referred to as lipodystrophies, also leads to severe metabolic disorders resulting in cardiovascular complications (16) .
In lipodystrophy, adipose tissue becomes unable to buffer excess circulating lipids and protect against its toxicity (15) , leading to further ectopic fat deposition, such as muscle, liver, and arteries (16, 37) .
Evidences in animal models and clinical studies indicate that the renin-angiotensin system (RAS) plays a major role in the development of cardiovascular and metabolic disorders, including vascular disease, diabetes, and nonalcoholic fatty liver disease (30, 33, 43) .
In the "classic" pathway of the RAS, renin is secreted by juxtaglomerular cells at the renal afferent arterioles and cleaves the liver-derived precursor protein angiotensinogen into the decapeptide angiotensin I (ANG I). ANG I is further hydrolyzed into the octapeptide angiotensin II (ANG II) by the angiotensin converting enzyme (ACE), which represents the main effector peptide of the RAS.
The identification of both ACE homologue ACE2 (10, 57) and of the angiotensin-(1-7) [ANG-(1-7)] Mas receptor (47) added a new complexity to the RAS. The ACE2/ANG-(1-7)/ Mas axis has been suggested as an important counterregulatory arm in the RAS with a number of important actions that oppose those of ANG II, including vasodilatation, antiproliferative, and antithrombotic effects (13, 46, 59) .
Recently, the ACE2/ANG-(1-7)/Mas axis has been also implicated in features of the metabolic syndrome and its related disorders (25, 36, 48, 49, 55, 56) . Previous studies from our group showed that Mas receptor deficiency induces to a metabolic syndrome-like state in FVB/N background mice (49) . In addition, increased levels of ANG-(1-7) have been shown to improve lipid profile, insulin resistance, hepatic fibrosis, and atherosclerosis (25, 36, 48, 55, 56) . These observations suggest that the RAS can play a pathophysiological role in metabolic syndrome-related disorders. However, further studies are necessary to clarify the role of specific component of the RAS, such as the ANG-(1-7) receptor, Mas, in these disorders.
Tesanovic and colleagues (55) reported that long-term ANG-(1-7) treatment in apolipoprotein E (ApoE)-knockout (KO) mice evoked improvement in endothelial function and atheroprotection, through an increase of nitric oxide bioavailability. However, the role of Mas in this effect was somehow inconclusive, since attenuation by both AT 2 and Mas receptor antagonists was observed. No studies have been performed using the Mas receptor deletion in a model of atherosclerosis, such as the ApoE-KO mice. This would be particularly important for clarifying the role of Mas in atherosclerosis. In addition, the results obtained with PD-123319 should be reevaluated, considering our recent findings concerning the nonspecificity of this compound, which can block actions of the novel angiotensin, alamandine, by interference with MrgD receptor (23) . This study aimed to start to elucidate these questions, specially the potential protective effects of Mas-triggered pathways in metabolic and inflammatory disorders (such as liver steatosis and atherosclerosis) using ApoE, Mas single KO, as well as Mas/ApoE-double-knockout (DKO) mice.
MATERIALS AND METHODS

Animals.
To generate Mas/ApoE-DKO mice, Mas-KO and ApoE-KO mice (based on C57BL/6 strain, transgenic animal facilities of the Laboratory of Hypertension, Federal University of Minas Gerais, Brazil) were bred to yield heterozygous mice. These mice were crossed and intercrossed to yield DKO mice, with genetic identity confirmed by tail genotyping at each generation. Twenty-week-old male C57BL/6 wild-type (WT), Mas-KO, ApoE-KO, and DKO were used for the experiments.
Mice were kept under controlled light and temperature conditions, with free access to water and standard diet. The animals were maintained according to the ethical guidelines of our institution, and the experimental protocol was approved by the Ethical Committee in Animals Experimentation of the Federal University of Minas Gerais (protocol no. 139/11).
Tissue collection. At 20 wk of age, all mice were killed after anesthesia using an intraperitoneal injection of ketamine (130 mg/kg) and xylazine (0.3 mg/kg), followed by exsanguination via femoral artery. Samples of epididymal white adipose tissue and liver were collected, weighted, and immediately frozen in liquid nitrogen and stored at Ϫ80°C for posterior analysis. Aortae and aortic roots were collected and placed in 10% neutral buffered formalin and quantitated for lesion area before being processed for subsequent immunohistochemical analysis.
Blood measurements. Serum triglycerides, total cholesterol (TC), and high-density lipoprotein (HDL) cholesterol were routinely measured using commercial kits (Labtest), as previously described (12) . Proatherogenic fraction was calculated as the difference between TC and HDL-cholesterol. ELISA kit was used to measure serum leptin (Millipore). Glucose levels were obtained from tail blood samples using an Optium Xceed glucometer (Abbott Laboratories). Serum insulin and resistin were determined using the xMAP technology (Milliplex, Millipore) reading magnetic beads through the equipment MagPix (Luminex Coorporation).
Determination of hepatic parameters. Hepatic total lipids were extracted using organic solvents according to the method described by Folch et al. (14) , gravimetrically quantified, and assayed for TC and triglycerides using enzymatic kits (Labtest Diagnostica). Alanine aminotransferase were measured using enzymatic kit (Bioclin). For the measurement of lipid peroxidation in liver homogenates, thiobarbituric acid reactive species (TBARS) assay were performed through the quantification of malondialdehyde, as previously described (4) .
Western blotting analysis. Seventy micrograms of protein were resolved on SDS-PAGE (10%) and then transferred onto nitrocellulose membranes. For immunoblotting, the membranes were probed with the following antibodies: rabbit polyclonal anti-␣-insulin receptor, ␤-subunit (1:1,000; Millipore); mouse monoclonal anti-LXR-␣ (liver X receptor, 1:1,000, Abcam); rabbit polyclonal anti-PPAR-␣ (peroxisome proliferator-activated receptor-␣, 1:1,000, Abcam); rabbit polyclonal anti-AT 1 receptor (1:500, Millipore); rabbit polyclonal anti-AT2 receptor (1:500, Millipore); mouse monoclonal anti-ACE (1:300, Millipore). The blots were then incubated with either IRDye goat-anti-rabbit or goat-anti-mouse IRDye 680 CW secondary antibody (Rockland Immunochemicals, Gilbertsville, PA), and ␤-actin (mouse monoclonal anti-␤-actin, 1:2,000, Sigma) was used as endogenous control. The blots were viewed using an infrared scanner from LICOR and analyzed using the Odyssey software.
Liver histology. Hepatic tissue was excised and fixed in formalin solution (4%) and embedded in Paraplast. Sections of the tissue were stained with hematoxylin and eosin. Sudam IV staining was performed on frozen sections 10 m thick. The images were analyzed qualitatively by another operator blinded to the identities of the animals.
Atherosclerotic lesion analysis. Five sections per mouse aortic sinus were stained with Oil Red O, as previously described (29) . Sections and aortas were counterstained with Mayer's hemalun and rinsed in distilled water. Quantifications were performed with MetaMorph software. Data were calculated as ratios of stained area on total lesion area. Aortae were dissected free of connective tissue, cut longitudinally, and stained with Sudan IV. Longitudinal aortic segments were then laid flat on a glass slide, and images were captured using a scanner and quantified using the appropriate software (Image Pro Plus 6.3, Bethesda, MD). Lesion area was expressed as a percentage of the total luminal surface area.
Immunohistochemistry in mouse aortic sinus plaques. Mouse aortic sinus was serially cut in 5-m transversal sections through the heart and aortic roots, as previously described (29) . Sections were fixed in acetone and immunostained with specific antibodies anti-mouse CD68 (macrophages, 1:400; ABD Serotec, Dusseldorf, Germany), antimouse CD3 (lymphocytes, 1:10; BD Pharmingen, Franklin Lakes, NJ), anti-mouse Ly-6B.2 (neutrophils, 1:50; ABD Serotec), antimouse matrix metalloproteinase (MMP)-8 (1:50; Santa Cruz Biotechnology, Santa Cruz, CA), anti-mouse MMP-9 (1:60; R&D Systems), and anti-mouse ␣-smooth muscle actin (1:200, Progen, Heildeberg, Germany). Quantifications were performed with MetaMorph software. Results were calculated as percentages of stained area on total lesion area or number of infiltrating cells on millimeters squared of lesion area.
Sirius red staining for collagen content. Five sections per mouse aortic sinus were rinsed with water and incubated with 0.1% Sirius red (Sigma Chemical, St. Louis, MO) in saturated picric acid for 90 min. Sections were rinsed twice with 0.01 N HCl for 1 min and then immersed in water. After dehydration with ethanol for 30 s and coverslipping, the sections were photographed with identical exposure settings under ordinary polychromatic or polarized light microscopy. Total collagen content was evaluated under polychromatic light. Quantifications were performed with MetaMorph software. Data were calculated as percentages of stained area on total lesion area.
Statistical analysis. Data are expressed as means Ϯ SE. The statistical significance of the difference in mean values between groups was assessed by an unpaired Student t-test or one-way ANOVA followed by Newman-Keuls test. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS
To characterize the DKO mouse line, we first investigated the potential relationship between body, fat, and liver weights. As observed in Table 1 , DKO mice presented a decrease in body weight (vs. WT and ApoE-KO) and in epididymal adipose tissue (vs. ApoE-KO), indicating that DKO have a substantial decrease in fat mass compared with ApoE-KO mice. There were no differences in liver weight between groups.
We observed that the absence of Mas receptor in ApoE-KO mice worsened dyslipidemia usually observed in this model ( Table 2) . DKO mice presented a significant increase in TC and triglyceride serum levels. A concomitant significant decrease in HDL was also observed. Altogether, these changes resulted in an increased proatherogenic fraction ( Table 2) .
The fasting serum glucose was similarly increased in Mas-KO, ApoE-KO, and DKO groups compared with WT mice. Insulin and resistin levels were similar in all mouse groups; however, leptin level was lower in the serum of DKO (Table 2) .
No significant difference in atherosclerotic plaque size (assessed by Sudan IV-stained surfaces, measured by "en face" method and within aortic root plaques) was shown between Mas/ApoE DKO and ApoE single-KO animals (Fig. 1) . Immunohistochemical staining of the aortic roots showed that the percentage of macrophages in atherosclerotic lesions was lower in the DKO group. However, deficiency of Mas in ApoE-KO mice was not associated with other modifications in neutrophil, collagen, MMP-9, MMP-8, lymphocyte, and smooth muscle cell intraplaque content (Table 3) .
To evaluate whether the absence of increased atherogenesis in the double Mas/ApoE mice could be due to altered lipid deposition, we next examined the liver in these animals. Strikingly, liver histological analysis showed in vivo degenerative changes of DKO hepatocytes associated with macro-and microvesicular steatosis, with inflammatory cell infiltration (Fig. 2, G and H) . In particular, ApoE mice showed inflammatory and degenerative changes partially induced by steatosis (Fig. 2, E and F) . The Mas-KO livers showed no relevant steatosis, or signal of degeneration, and few mononuclear inflammatory foci (Fig. 2, C and D) . In accordance with these histological observations, a marked increase in liver lipid accumulation was shown in the DKO mice compared with the other groups (Table 4) . Furthermore, ApoE-KO and DKO presented a significant increase in serum alanine aminotransferase levels (WT ϭ 11.3 Ϯ 1.7; Mas-KO ϭ 23.1 Ϯ 6.8; ApoE-KO ϭ 62.3 Ϯ 5.8; DKO ϭ 69.4 Ϯ 10.4 U/ml, n ϭ 6) (Fig. 3A) . Since lipid peroxidation products play an important role in the pathogenesis of nonalcoholic fatty liver disease (5), we next examined serum and hepatic levels of TBARS. As shown in Fig. 3B , an increase in TBARS levels in liver of DKO mice was observed (WT ϭ 0.58 Ϯ 0.04; Mas-KO ϭ 0.74 Ϯ 0.09; ApoE-KO ϭ 0.57 Ϯ 0.02; DKO ϭ 0.79 Ϯ 0.09 M malondialdehyde/g protein, n ϭ 6).
To identify the molecular mechanisms underlying the development of hepatic steatosis in DKO mice, we focused on insulin receptor, PPAR-␣, and LXR. As shown in Fig. 4A , Western blot analysis revealed a significant relative decreased hepatic expression of the insulin receptor in DKO mice compared with WT and single ApoE-KO (WT ϭ 0.74 Ϯ 0.08; Mas-KO ϭ 0.57 Ϯ 0.11; ApoE-KO ϭ 0.70 Ϯ 0.07; DKO ϭ 0.32 Ϯ 0.05 arbitrary units, n ϭ 6), potentially indicating a hepatic insulin resistance. The liver expression PPAR-␣ protein was also reduced in DKO compared with ApoE-KO mice (WT ϭ 0.08 Ϯ 0.006, n ϭ 6; Mas-KO ϭ 0.09 Ϯ 0.01, n ϭ 5; ApoE-KO ϭ 0.09 Ϯ 0.007, n ϭ 6; DKO ϭ 0.06 Ϯ 0.008 arbitrary units, n ϭ 6) (Fig. 4B) . The hepatic protein expression of LXR was in ApoE-KO (WT ϭ 9.7 Ϯ 2.3 vs. ApoE-KO ϭ 4.4 Ϯ 0.6 arbitrary units; Fig. 4C ). However, in Mas-KO mice, ApoE deficiency was associated to normal LXR expression (DKO ϭ 11.3 Ϯ 1.4, n ϭ 6 vs. WT ϭ 9.7 Ϯ 2.3 arbitrary units; Fig. 4C ).
We also evaluated the liver expression of RAS components such as ACE, and both ANG II receptors AT 1 and AT 2 . The hepatic expression of AT 1 and ACE were reduced in ApoE-KO compared with Mas-KO and WT, respectively. There were no significant differences in these RAS components between the other groups (Fig. 5) .
DISCUSSION
The RAS and lipid profile alteration are two of the most relevant routes of metabolic regulation (24, 26, 36, 45) . In the present study, we evaluated the potential participation of Mas receptor, a main component of the ACE2/ANG-(1-7)/Mas axis of the RAS, in the liver metabolism and atherosclerosis. We took advantage of the availability of Mas receptor and ApoEdeficient mice to generate a DKO mice. We observed that Mas deficiency in ApoE mice produced a lipodystrophy-like state characterized by a marked diminished body weight and white adipose tissue mass associated to severe liver steatosis.
ANG-(1-7)/Mas axis has been described as an important hormonal component involved in lipid and glucose metabolic regulation (17, 24, 40, 48) . Mas-KO FVB/N mice were char- acterized as a metabolic syndromelike state model with dyslipidemia, hypertension, and endothelial dysfunction (49, 59) . On the other hand, apolipoproteins are described as fundamental in the lipid transport. ApoE is one of the most described apolipoprotein, and its major function is to remove triglycerides-rich lipoproteins from circulation (26) . ApoE deletion commonly leads to atherosclerotic disease (38 -39, 41) . In this context, the new DKO mice Mas/ApoE is an innovative model to study metabolic regulation. Because ApoE genetic deletion produces a stronger phenotype in C57BL/6 mice (9), we used, in the present study, Mas-KO mice in this background, although, in C57BL/6 mice, Mas deletion produced only mild changes in lipid metabolism (49) . Indeed, we observed that Mas KO mice presented reduced adipose tissue mass, contrasting with our laboratory's previous study showing an increased fat mass in FVB/N Mas-KO mice (49) . A similar reduction of white adipose tissue mass was observed in the DKO mice. Accordingly, Mario and colleagues (27) demonstrated that the deletion of the Mas receptor decreases the PPAR-␥ expression, transcription factor that is believed to be a master regulator of lipogenesis (44) . To investigate if such changes in C57Bl6 background were due to a lipodystrophy-like state, we evaluated fat liver deposition. Strikingly, we observed a severe steatosis in DKO model, pointing out for a switched site of lipid deposition. This Values are means Ϯ SE; n, no. of mice. MMP-9, matrix metalloproteinase-9; MMP-8, matrix metalloproteinase-8; SMC, smooth muscle cell. †P Յ 0.05 vs. ApoE-KO.
hypothesis was corroborated by the altered expression of insulin receptor, which is responsible for the liver lipid and glucose metabolism (19) , and reduced PPAR-␣, which controls lipid oxidation and transport (58) . Furthermore, increased circulating triglyceride, TC, and diminished HDL-cholesterol support the theory of lipid metabolic unbalance.
It is well established that the intrahepatic expression of ACE/ANG II/AT 1 axis is increased in experimental liver injury (3, 34) . Moreover, deletion or blockade of components of this axis improves experimental hepatic steatosis and fibrosis (20, 22, 30, 53) . In our study, increases in liver lipid content in DKO group were not accompanied by alterations in RAS components expression. In this regard, further studies are needed to identify the precise mechanisms involved in the possible association of the worsening of hepatic steatosis and the RAS members expression in the DKO mice. It should pointed out, however, that our present results suggest a primary role for the absence of Mas receptor in this increase of hepatic steatosis in the double ApoE/Mas mice.
Leptin is an important adipokine involved in the central satiety and also regulates local tissue lipid metabolism (1, 8) . Several studies showed that circulating leptin reduction induced hyperphagia and a positive energy balance, contributing to ectopic fat deposition (50) . Treatment with recombinant leptin in lipodystrophy patients reverses many of its metabolic disturbances (32, 37) . Also, some animal models of lipodystrophy showed reduced leptin plasma levels (11, 18, 52) , as observed in the present study in the DKO mice.
The ApoE-KO mice represent a well-recognized model of animals prone to develop atherosclerosis (38 -39) . As previously described (29) , our laboratory evaluated aortic arch and aortic root lipid content as a validated method to estimate atherosclerotic entity. No difference between groups was observed on plaque size. Corroborating these data, we did not observe any increase in the intraplaque inflammatory profile (assessed by neutrophil, MMP-9, MMP-8, macrophage, lymphocyte, smooth muscle cell, and collagen content). These results can be, at least in part, attributed to the increased liver expression of LXR. The LXR is considered a cholesterol sensor that regulates several genes involved in lipid metabolic regulation (60) . Several studies showed the benefits of LXR in the atherosclerosis treatment (21, 35) . Despite all of the metabolic improvement produced by LXR activation, some studies pointed out some side effects, including activation of hepatic lipogenesis and increased reverse cholesterol transport (31, 42, 51) , which can explain partially the observed liver steatosis. Furthermore, leptin has proinflammatory properties, and leptindeficient mice exhibit an impaired immune function with diminished cellularity in spleen and thymus and reduced secretion of proinflammatory cytokines (6, 45) . In addition, studies have shown that leptin deficiency reduces atherosclerotic lesions in both low-density lipoprotein receptor and ApoE-KO mice (7, 54) . These mechanisms are probably contributing to the phenotype observed, especially considering that, in this study, we used mice under standard non-high-fat diet.
Perspectives and Significance
The present study showed for the first time that Mas deletion in ApoE-KO mice produced a devastating metabolic profile, leading to lipodystrophy-like state with severe liver steatosis and dyslipidemia. These results pointed out an important participation of Mas receptor in liver health, indicating that ANG-(1-7) could be considered as a putative new and innovative therapeutic drug for the treatment of liver diseases and metabolic-syndrome-associated disorders. 
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